Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Trial for Glutamine Therapy for Hemolysis-Associated Pulmonary Hypertension

NCT01048905 is registered in ClinicalTrials.gov with UCSF Benioff Children's Hospital Oakland as lead sponsor.

NCT NCT01048905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01048905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Trial for Glutamine Therapy for Hemolysis-Associated Pulmonary Hypertension
Lead sponsor
UCSF Benioff Children's Hospital Oakland
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2009
Completion date
March 31, 2014
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary hypertension, sickle cell disease, thalassemia